Living with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease or Motor Neuron Disease, presents profound challenges for patients and their caregivers. As a progressive neurodegenerative disease that affects motor neurons, ALS leads to gradual loss of muscle control, significantly impacting quality of life and independence for approximately 3,000 Canadians currently living with the condition.
ALS progresses differently in each person, but the core experience involves the degeneration of motor neurons, leading to muscle weakness, atrophy, and eventually affecting the ability to move, speak, eat, and breathe. With limited treatment options available, many patients and caregivers seek complementary approaches to manage symptoms and improve quality of life.
Some common challenges faced by people with ALS include:
- Progressive muscle weakness and paralysis
- Spasticity and muscle cramps
- Difficulty speaking and swallowing (dysarthria and dysphagia)
- Respiratory compromise
- Pain and discomfort
- Sleep disturbances
- Excessive saliva and secretions
- Emotional and psychological distress
- Loss of independence
Traditional treatments typically involve riluzole and edaravone (medications that may slow disease progression), along with multidisciplinary supportive care focusing on symptom management. However, these approaches provide limited benefits, and many symptoms remain inadequately controlled. This reality has led many ALS patients and their healthcare providers to explore alternative options, including medical cannabis.